These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 23176415

  • 1. Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM, Jergens AE, Ackermann MR, Barr JW, Suchodolski JS, Steiner JM.
    Am J Vet Res; 2012 Dec; 73(12):1900-7. PubMed ID: 23176415
    [Abstract] [Full Text] [Related]

  • 2. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M, Hörauf A, Bilzer T.
    Berl Munch Tierarztl Wochenschr; 2006 Dec; 119(11-12):493-505. PubMed ID: 17172138
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease.
    McCann TM, Ridyard AE, Else RW, Simpson JW.
    J Small Anim Pract; 2007 Nov; 48(11):620-5. PubMed ID: 17608662
    [Abstract] [Full Text] [Related]

  • 4. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM, Grellet A, Allenspach K, Lecoindre P, Day MJ, Priestnall SL, Toresson L, Procoli F, Grützner N, Suchodolski JS, Steiner JM.
    Vet Immunol Immunopathol; 2014 Apr 15; 158(3-4):156-66. PubMed ID: 24518653
    [Abstract] [Full Text] [Related]

  • 5. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
    Jergens AE, Crandell J, Morrison JA, Deitz K, Pressel M, Ackermann M, Suchodolski JS, Steiner JM, Evans R.
    J Vet Intern Med; 2010 Apr 15; 24(2):269-77. PubMed ID: 20051005
    [Abstract] [Full Text] [Related]

  • 6. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
    Otoni CC, Heilmann RM, García-Sancho M, Sainz A, Ackermann MR, Suchodolski JS, Steiner JM, Jergens AE.
    J Vet Intern Med; 2018 May 15; 32(3):999-1008. PubMed ID: 29624721
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 15; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 8. Fecal calprotectin concentrations in adult dogs with chronic diarrhea.
    Grellet A, Heilmann RM, Lecoindre P, Feugier A, Day MJ, Peeters D, Freiche V, Hernandez J, Grandjean D, Suchodolski JS, Steiner JM.
    Am J Vet Res; 2013 May 15; 74(5):706-11. PubMed ID: 23627383
    [Abstract] [Full Text] [Related]

  • 9. Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
    Heilmann RM, Berghoff N, Mansell J, Grützner N, Parnell NK, Gurtner C, Suchodolski JS, Steiner JM.
    J Vet Intern Med; 2018 Mar 15; 32(2):679-692. PubMed ID: 29460444
    [Abstract] [Full Text] [Related]

  • 10. Development and analytic validation of a radioimmunoassay for the quantification of canine calprotectin in serum and feces from dogs.
    Heilmann RM, Suchodolski JS, Steiner JM.
    Am J Vet Res; 2008 Jul 15; 69(7):845-53. PubMed ID: 18593232
    [Abstract] [Full Text] [Related]

  • 11. Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease.
    Gunawardana SC, Jergens AE, Ahrens FA, Niyo Y.
    J Am Vet Med Assoc; 1997 Aug 01; 211(3):318-21. PubMed ID: 9262670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS.
    Scand J Gastroenterol; 2007 Nov 01; 42(11):1321-31. PubMed ID: 17852869
    [Abstract] [Full Text] [Related]

  • 14. A scoring index for disease activity in canine inflammatory bowel disease.
    Jergens AE, Schreiner CA, Frank DE, Niyo Y, Ahrens FE, Eckersall PD, Benson TJ, Evans R.
    J Vet Intern Med; 2003 Nov 01; 17(3):291-7. PubMed ID: 12774968
    [Abstract] [Full Text] [Related]

  • 15. Duodenal and colonic mucosal S100A8/A9 (calprotectin) expression is increased and correlates with the severity of select histologic lesions in dogs with chronic inflammatory enteropathy.
    Nestler J, Syrjä P, Kilpinen S, Moniz CA, Spillmann T, Hanifeh M, Heilmann RM.
    BMC Vet Res; 2024 Sep 06; 20(1):393. PubMed ID: 39238011
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct 06; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 19. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL, Abreu MT.
    Gastroenterol Clin Biol; 2009 Jun 06; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [Abstract] [Full Text] [Related]

  • 20. CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease.
    Kathrani A, Schmitz S, Priestnall SL, Smith KC, Werling D, Garden OA, Allenspach K.
    J Comp Pathol; 2011 Nov 06; 145(4):359-66. PubMed ID: 21592490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.